The thalamus plays a crucial role in sensory processing, emotional regulation, and cognitive functions, and its dysregulation may be implicated in psychosis. The aim of the present study was to examine the differences in thalamic subregional volumes between pediatric bipolar disorder patients with (P-PBD) and without psychotic symptoms (NP-PBD). Participants including 28 P-PBD, 26 NP-PBD, and 18 healthy controls (HCs) underwent structural magnetic resonance imaging (sMRI) scanning using a 3.0T MRI scanner. All T1-weighted imaging data were processed by FreeSurfer 7.4.0 software. The volumetric differences of thalamic subregions among three groups were compared by using analyses of covariance (ANCOVA) and post-hoc analyses. Additionally, we applied a standard support vector classification (SVC) model for pairwise comparison among the three groups to identify brain regions with significant volumetric differences. The ANCOVA revealed that significant volumetric differences were observed in the left pulvinar anterior (L_PuA) and left reuniens medial ventral (L_MV-re) thalamus among three groups. Post-hoc analysis revealed that patients with P-PBD exhibited decreased volumes in the L_PuA and L_MV-re when compared to the NP-PBD group and HCs, respectively. Furthermore, the SVC model revealed that the L_MV-re volume exhibited the best capacity to discriminate P-PBD from NP-PBD and HCs. The present findings demonstrated that reduced thalamic subregional volumes in the L_PuA and L_MV-re might be associated with psychotic symptoms in PBD.

Accurate preoperative discrimination of salivary gland pleomorphic adenoma (SPA) stromal subtypes is essential for therapeutic plannings. We aimed to establish and test machine learning (ML) models for classification of stromal subtypes in SPA based on ultrasound histogram analysis. A total of 256 SPA patients were enrolled in the study and categorized into two groups: stroma-low and stroma-high. The dataset was split into a training cohort with 177 patients and a validation cohort with 79 patients. The least absolute shrinkage and selection operator (LASSO) regression identified optimal features, which were then utilized to build predictive models using logistic regression (LR) and eight ML algorithms. The effectiveness of the models was evaluated using a range of performance metrics, with a particular focus on the area under the receiver operating characteristic curve (AUC). After LASSO regression, six key features (lesion size, shape, cystic areas, vascularity, mean, and skewness) were selected to develop predictive models. The AUCs ranged from 0.575 to 0.827 for the nine models. The support vector machine (SVM) algorithm achieved the highest performance with an AUC of 0.827, accompanied by an accuracy of 0.798, precision of 0.792, recall of 0.862, and an F1 score of 0.826. The LR algorithm also exhibited robust performance, achieving an AUC of 0.818, slightly trailing behind the SVM algorithm. Decision curve analysis indicated that the SVM-based model provided superior clinical utility compared to other models. The ML model based on ultrasound histogram analysis offers a precise and non-invasive approach for preoperative categorization of stromal subtypes in SPA.

During radiation therapy, the natural movement of organs can lead to underdosing the cancer and overdosing the healthy tissue, compromising treatment efficacy. Real-time image-guided adaptive radiation therapy can track the tumour and account for the motion. Typically, fiducial markers are implanted as a surrogate for the tumour position due to the low radiographic contrast of soft tissues in kilovoltage (kV) images. A segmentation approach that does not require markers would eliminate the costs, delays, and risks associated with marker implantation. We trained patient-specific conditional Generative Adversarial Networks for prostate segmentation in kV images. The networks were trained using synthetic kV images generated from each patient's own imaging and planning data, which are available prior to the commencement of treatment. We validated the networks on two treatment fractions from 30 patients using multi-centre data from two clinical trials. Here, we present a large-scale proof-of-principle study of x-ray-based markerless prostate segmentation for globally available cancer therapy systems. Our results demonstrate the feasibility of a deep learning approach using kV images to track prostate motion across the entire treatment arc for 30 patients with prostate cancer. The mean absolute deviation is 1.4 and 1.6 mm in the anterior-posterior/lateral and superior-inferior directions, respectively. Markerless segmentation via deep learning may enable real-time image guidance on conventional cancer therapy systems without requiring implanted markers or additional hardware, thereby expanding access to real-time adaptive radiation therapy.

This study introduces a novel methodology to enhance nipple segmentation in digital mammography, a critical component for accurate medical analysis and computer-aided detection systems. The nipple is a key anatomical landmark for multi-view and multi-modality breast image registration, where accurate localization is vital for ensuring image quality and enabling precise registration of anomalies across different mammographic views. The proposed approach significantly outperforms baseline methods, particularly in challenging cases where previous techniques failed. It achieved successful detection across all cases and reached a mean Intersection over Union (mIoU) of 0.63 in instances where the baseline failed entirely. Additionally, it yielded nearly a tenfold improvement in Hausdorff distance and consistent gains in overlap-based metrics, with the mIoU increasing from 0.7408 to 0.8011 in the craniocaudal (CC) view and from 0.7488 to 0.7767 in the mediolateral oblique (MLO) view. Furthermore, its generalizability suggests the potential for application to other breast imaging modalities and related domains facing challenges such as class imbalance and high variability in object characteristics.

Novel artificial intelligence tools have the potential to significantly enhance productivity in medicine, while also maintaining or even improving treatment quality. In this study, we aimed to evaluate the current capability of ChatGPT-4.0 to accurately interpret multimodal musculoskeletal tumor cases.We created 25 cases, each containing images from X-ray, computed tomography, magnetic resonance imaging, or scintigraphy. ChatGPT-4.0 was tasked with classifying each case using a six-option, two-choice question, where both a primary and a secondary diagnosis were allowed. For performance evaluation, human raters also assessed the same cases.When only the primary diagnosis was taken into account, the accuracy of human raters was greater than that of ChatGPT-4.0 by a factor of nearly 2 (87% vs. 44%). However, in a setting that also considered secondary diagnoses, the performance gap shrank substantially (accuracy: 94% vs. 71%). Power analysis relying on Cohen's w confirmed the adequacy of the sample set size (n: 25).The tested artificial intelligence tool demonstrated lower performance than human raters. Considering factors such as speed, constant availability, and potential future improvements, it appears plausible that artificial intelligence tools could serve as valuable assistance systems for doctors in future clinical settings. · ChatGPT-4.0 classifies musculoskeletal cases using multimodal imaging inputs.. · Human raters outperform AI in primary diagnosis accuracy by a factor of nearly two.. · Including secondary diagnoses improves AI performance and narrows the gap.. · AI demonstrates potential as an assistive tool in future radiological workflows.. · Power analysis confirms robustness of study findings with the current sample size.. · Bosbach WA, Schoeni L, Beisbart C et al. Evaluating the Diagnostic Accuracy of ChatGPT-4.0 for Classifying Multimodal Musculoskeletal Masses: A Comparative Study with Human Raters. Rofo 2025; DOI 10.1055/a-2594-7085.

This paper describes PARADIM, a digital infrastructure designed to support research at the interface of data science and medical imaging, with a focus on Research Data Management best practices. The platform is built from open-source components and rooted in the FAIR principles through strict compliance with the DICOM standard. It addresses key needs in data curation, governance, privacy, and scalable resource management. Supporting every stage of the data science discovery cycle, the platform offers robust functionalities for user identity and access management, data de-identification, storage, annotation, as well as model training and evaluation. Rich metadata are generated all along the research lifecycle to ensure the traceability and reproducibility of results. PARADIM hosts several medical image collections and allows the automation of large-scale, computationally intensive pipelines (e.g., automatic segmentation, dose calculations, AI model evaluation). The platform fills a gap at the interface of data science and medical imaging, where digital infrastructures are key in the development, evaluation, and deployment of innovative solutions in the real world.

Cancer is among the most dangerous diseases contributing to rising global mortality rates. Lung cancer, particularly adenocarcinoma, is one of the deadliest forms and severely impacts human life. Early diagnosis and appropriate treatment significantly increase patient survival rates. Computed Tomography (CT) is a preferred imaging modality for detecting lung cancer, as it offers detailed visualization of tumor structure and growth. With the advancement of deep learning, the automated identification of lung cancer from CT images has become increasingly effective. This study proposes a novel lung cancer detection framework using a Flower Pollination Algorithm (FPA)-based weighted ensemble of three high-performing pretrained Convolutional Neural Networks (CNNs): VGG16, ResNet101V2, and InceptionV3. Unlike traditional ensemble approaches that assign static or equal weights, the FPA adaptively optimizes the contribution of each CNN based on validation performance. This dynamic weighting significantly enhances diagnostic accuracy. The proposed FPA-based ensemble achieved an impressive accuracy of 98.2%, precision of 98.4%, recall of 98.6%, and an F1 score of 0.985 on the test dataset. In comparison, the best individual CNN (VGG16) achieved 94.6% accuracy, highlighting the superiority of the ensemble approach. These results confirm the model's effectiveness in accurate and reliable cancer diagnosis. The proposed study demonstrates the potential of deep learning and neural networks to transform cancer diagnosis, helping early detection and improving treatment outcomes.

Magnetic resonance imaging (MRI) is essential in clinical and research contexts, providing exceptional soft-tissue contrast. However, prolonged acquisition times often lead to patient discomfort and motion artifacts. Diffusion-based deep learning super-resolution (SR) techniques reconstruct high-resolution (HR) images from low-resolution (LR) pairs, but they involve extensive sampling steps, limiting real-time application. To overcome these issues, this study introduces a residual error-shifting mechanism markedly reducing sampling steps while maintaining vital anatomical details, thereby accelerating MRI reconstruction. We developed Res-SRDiff, a novel diffusion-based SR framework incorporating residual error shifting into the forward diffusion process. This integration aligns the degraded HR and LR distributions, enabling efficient HR image reconstruction. We evaluated Res-SRDiff using ultra-high-field brain T1 MP2RAGE maps and T2-weighted prostate images, benchmarking it against Bicubic, Pix2pix, CycleGAN, SPSR, I2SB, and TM-DDPM methods. Quantitative assessments employed peak signal-to-noise ratio (PSNR), structural similarity index (SSIM), gradient magnitude similarity deviation (GMSD), and learned perceptual image patch similarity (LPIPS). Additionally, we qualitatively and quantitatively assessed the proposed framework's individual components through an ablation study and conducted a Likert-based image quality evaluation. Res-SRDiff significantly surpassed most comparison methods regarding PSNR, SSIM, and GMSD for both datasets, with statistically significant improvements (p-values≪0.05). The model achieved high-fidelity image reconstruction using only four sampling steps, drastically reducing computation time to under one second per slice. In contrast, traditional methods like TM-DDPM and I2SB required approximately 20 and 38 seconds per slice, respectively. Qualitative analysis showed Res-SRDiff effectively preserved fine anatomical details and lesion morphologies. The Likert study indicated that our method received the highest scores, 4.14±0.77(brain) and 4.80±0.40(prostate). Res-SRDiff demonstrates efficiency and accuracy, markedly improving computational speed and image quality. Incorporating residual error shifting into diffusion-based SR facilitates rapid, robust HR image reconstruction, enhancing clinical MRI workflow and advancing medical imaging research. Code available at https://github.com/mosaf/Res-SRDiff.

The imaging of inflammatory myelopathies has advanced significantly across time, with MRI techniques playing a pivotal role in enhancing lesion detection. However, the impact of deep learning (DL)-based reconstruction on 3D double inversion recovery (DIR) imaging for inflammatory myelopathies remains unassessed. This study aimed to compare the acquisition time, image quality, diagnostic confidence, and lesion detection rates among sagittal T2WI, standard DIR, and DL-reconstructed DIR in patients with inflammatory myelopathies. In this observational study, patients diagnosed with inflammatory myelopathies were recruited between June 2023 and March 2024. Each patient underwent sagittal conventional TSE sequences and standard 3D DIR (T2WI and standard 3D DIR were used as references for comparison), followed by an undersampled accelerated double inversion recovery deep learning (DIR_DL) examination. Three neuroradiologists evaluated the images using a 4-point Likert scale (from 1 to 4) for overall image quality, perceived SNR, sharpness, artifacts, and diagnostic confidence. The acquisition times and lesion detection rates were also compared among the acquisition protocols. A total of 149 participants were evaluated (mean age, 40.6 [SD, 16.8] years; 71 women). The median acquisition time for DIR_DL was significantly lower than for standard DIR (298 seconds [interquartile range, 288-301 seconds] versus 151 seconds [interquartile range, 148-155 seconds]; <i>P</i> < .001), showing a 49% time reduction. DIR_DL images scored higher in overall quality, perceived SNR, and artifact noise reduction (all <i>P</i> < .001). There were no significant differences in sharpness (<i>P</i> = .07) or diagnostic confidence (<i>P</i> = .06) between the standard DIR and DIR_DL protocols. Additionally, DIR_DL detected 37% more lesions compared with T2WI (300 versus 219; <i>P</i> < .001). DIR_DL significantly reduces acquisition time and improves image quality compared with standard DIR, without compromising diagnostic confidence. Additionally, DIR_DL enhances lesion detection in patients with inflammatory myelopathies, making it a valuable tool in clinical practice. These findings underscore the potential for incorporating DIR_DL into future imaging guidelines.

Traditional guidance for intracranial aneurysm (IA) management is dichotomized by rupture status. Fundamental to the management of ruptured aneurysm is the detection and treatment of SAH, along with securing the aneurysm by the safest technique. On the other hand, unruptured aneurysms first require a careful assessment of their natural history versus treatment risk, including an imaging assessment of aneurysm size, location, and morphology, along with additional evidence-based risk factors such as smoking, hypertension, and family history. Unfortunately, a large proportion of ruptured aneurysms are in the lower risk size category (<7 mm), putting a premium on discovering a more refined noninvasive biomarker to detect and stratify aneurysm instability before rupture. In this review of aneurysm work-up, we cover the gamut of established imaging modalities (eg, CT, CTA, DSA, FLAIR, 3D TOF-MRA, contrast-enhanced-MRA) as well as more novel MR techniques (MR vessel wall imaging, dynamic contrast-enhanced MRI, computational fluid dynamics). Additionally, we evaluate the current landscape of artificial intelligence software and its integration into diagnostic and risk-stratification pipelines for IAs. These advanced MR techniques, increasingly complemented with artificial intelligence models, offer a paradigm shift by evaluating factors beyond size and morphology, including vessel wall inflammation, permeability, and hemodynamics. Additionally, we provide our institution's scan parameters for many of these modalities as a reference. Ultimately, this review provides an organized, up-to-date summary of the array of available modalities/sequences for IA imaging to help build protocols focused on IA characterization.